Raban Jeger
Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.
Wagener M, Boeddinghaus J, Gaemperli O, Räber L, Nietlispach F, Meier P, Muller O, Weilenmann D, Jeger R. Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey. J Clin Med 2022; 11
15.12.2022Trends in Coronary and Structural Heart Interventions in Switzerland over the Last 16 Years and Impact of COVID-19: Insights from the National Swiss PCI Survey.
15.12.2022J Clin Med 2022; 11
Wagener Max, Boeddinghaus Jasper, Gaemperli Oliver, Räber Lorenz, Nietlispach Fabian, Meier Pascal, Muller Olivier, Weilenmann Daniel, Jeger Raban
Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction.
Foster-Witassek F, Rickli H, Roffi M, Pedrazzini G, Eberli F, Fassa A, Jeger R, Fournier S, Erne P, Radovanovic D. Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction. Eur J Prev Cardiol 2022
13.12.2022Reducing gap in pre-hospital delay between women and men presenting with ST-Elevation myocardial infarction.
13.12.2022Eur J Prev Cardiol 2022
Foster-Witassek Fabienne, Rickli Hans, Roffi Marco, Pedrazzini Giovanni, Eberli Franz, Fassa Amir, Jeger Raban, Fournier Stephane, Erne Paul, Radovanovic Dragana
Coronary and structural heart interventions in Switzerland 2019
Wagener M, Jeger R, Weilenmann D, Räber L, Nietlispach F, Muller O, Meier P, Gämperli O, Cook S, Twerenbold R, On Behalf Of The Swiss Working Group Interventional Cardiology Of The Swiss Society Of Cardiology. Coronary and structural heart interventions in Switzerland 2019. Swiss Med Wkly 2021; 151:w20495.
11.05.2021Coronary and structural heart interventions in Switzerland 2019
11.05.2021Swiss Med Wkly 2021; 151:w20495
Wagener Max, Jeger Raban, Weilenmann Daniel, Räber Lorenz, Nietlispach Fabian, Muller Olivier, Meier Pascal, Gämperli Oliver, Cook Stéphane, Twerenbold Raphael, On Behalf Of The Swiss Working Group Interventional Cardiology Of The Swiss Society Of Cardiology
Infective endocarditis: prevention and antibiotic prophylaxis
Sendi P, Knirsch W, Agyeman P, Zbinden S, Jeger R, Guery B, Boggian K, Fluckiger U, Frank M, Hasse B, Greutmann M. Infective endocarditis: prevention and antibiotic prophylaxis. Swiss Med Wkly 2021; 151:w20473.
28.02.2021Infective endocarditis: prevention and antibiotic prophylaxis
28.02.2021Swiss Med Wkly 2021; 151:w20473
Sendi Parham, Knirsch Walter, Agyeman Philipp, Zbinden Stephan, Jeger Raban, Guery Benoit, Boggian Katia, Fluckiger Ursula, Frank Michelle, Hasse Barbara, Greutmann Matthias
Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
Tersalvi G, Erne P, Moccetti T, Jeger R, Moccetti M, Eberli F, Roffi M, Rickli H, Radovanovic D, Biasco L, Pedrazzini G. Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry. Cardiology 2020; 145:757-765.
20.08.2020Heavy Drinking Habits Are Associated with Worse In-Hospital Outcomes in Patients with Acute Coronary Syndrome: An Insight from the AMIS Plus Registry
20.08.2020Cardiology 2020; 145:757-765
Tersalvi Gregorio, Erne Paul, Moccetti Tiziano, Jeger Raban, Moccetti Marco, Eberli Franz, Roffi Marco, Rickli Hans, Radovanovic Dragana, Biasco Luigi, Pedrazzini Giovanni
Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry
Hunziker L, Pilgrim T, Rickli H, Erne P, Urban P, Cuculi F, Pedrazzini G, Jeger R, Radovanovic D, AMIS Plus Registry Investigators are listed in alphabetic order with the names of the local principal investigators. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry. Circ Cardiovasc Interv 2019; 12:e007293.
01.01.2019Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry
01.01.2019Circ Cardiovasc Interv 2019; 12:e007293
Hunziker Lukas, Pilgrim Thomas, Rickli Hans, Erne Paul, Urban Philip, Cuculi Florim, Pedrazzini Giovanni, Jeger Raban, Radovanovic Dragana, AMIS Plus Registry Investigators are listed in alphabetic order with the names of the local principal investigators
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2
Gilgen N, Butter C, Bruch L, Kaiser C, Hoffmann A, Rickenbacher P, Mueller C, Stephan F, Coslovsky M, Jeger R, Krackhardt F, Zweiker R, Farah A, Scheller B, Ohlow M, Mangner N, Weilenmann D, Wöhrle J, Jamshidi P, Leibundgut G, Möbius-Winkler S, BASKET-SMALL 2 Investigators. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2. Clin Cardiol 2018; 41:569-575.
10.05.2018Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2
10.05.2018Clin Cardiol 2018; 41:569-575
Gilgen Nicole, Butter Christian, Bruch Leonhard, Kaiser Christoph, Hoffmann Andreas, Rickenbacher Peter, Mueller Christian, Stephan Frank-Peter, Coslovsky Michael, Jeger Raban, Krackhardt Florian, Zweiker Robert, Farah Ahmed, Scheller Bruno, Ohlow Marc-Alexander, Mangner Norman, Weilenmann Daniel, Wöhrle Jochen, Jamshidi Peiman, Leibundgut Gregor, Möbius-Winkler Sven, BASKET-SMALL 2 Investigators
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis
Biasco L, Erne P, Moccetti T, Jeger R, Eberli F, Roffi M, Rickli H, Moccetti M, Radovanovic D, Pedrazzini G. New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis. Rev Esp Cardiol (Engl Ed) 2018
10.04.2018New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis
10.04.2018Rev Esp Cardiol (Engl Ed) 2018
Biasco Luigi, Erne Paul, Moccetti Tiziano, Jeger Raban, Eberli Franz, Roffi Marco, Rickli Hans, Moccetti Marco, Radovanovic Dragana, Pedrazzini Giovanni
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
Kaiser C, Vuillomenet A, Steiner M, von Felten S, Vogt D, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M, Weilenmann D, Rickli H, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz D, Pedrazzini G, Moccetti T, BASKET-PROVE II study group. Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial. Circulation 2014; 131:74-81.
19.11.2014Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial
19.11.2014Circulation 2014; 131:74-81
Kaiser Christoph, Vuillomenet André, Steiner Martin, von Felten Stefanie, Vogt Deborah R, Wadt Hansen Kim, Rickenbacher Peter, Conen David, Müller Christian, Buser Peter, Hoffmann Andreas, Pfisterer Matthias, Weilenmann Daniel, Rickli Hans, Galatius Soeren, Jeger Raban, Gilgen Nicole, Skov Jensen Jan, Naber Christoph, Alber Hannes, Wanitschek Maria, Eberli Franz, Kurz David J, Pedrazzini Giovanni, Moccetti Tiziano, BASKET-PROVE II study group
Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
Jeger R, Gilgen N, Vuilliomenet A, Jensen J, Rickli H, Pedrazzini G, Naber C, Galatius S, Eberli F, Alber H, Pfisterer M, Kaiser C. Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design. Am Heart J 2012; 163:136-41.e1.
01.02.2012Newest-generation drug-eluting and bare-metal stents combined with prasugrel-based antiplatelet therapy in large coronary arteries: the BAsel Stent Kosten Effektivitäts Trial PROspective Validation Examination part II (BASKET-PROVE II) trial design
01.02.2012Am Heart J 2012; 163:136-41.e1
Jeger Raban, Gilgen Nicole, Vuilliomenet André, Jensen Jan Skov, Rickli Hans, Pedrazzini Giovanni, Naber Christoph, Galatius Søren, Eberli Franz, Alber Hannes, Pfisterer Matthias, Kaiser Christoph
Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease
Filipovic M, Jeger R, Probst C, Girard T, Pfisterer M, Gürke L, Skarvan K, Seeberger M. Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease. Journal of the American College of Cardiology 2003; 42:1767-76.
19.11.2003Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease
19.11.2003Journal of the American College of Cardiology 2003; 42:1767-76
Filipovic Miodrag, Jeger Raban, Probst Cecilia, Girard Thierry, Pfisterer Matthias, Gürke Lorenz, Skarvan Karl, Seeberger Manfred D